18 results
10-Q
2024 Q1
NAMS
NewAmsterdam Pharma Company NV
8 May 24
Quarterly report
4:30pm
, testing, manufacturing, labeling, packaging, approval, promotion, advertising, storage, recordkeeping, marketing, distribution, post-approval monitoring … , labeling, packaging, distribution, AE reporting, storage, advertising, promotion and recordkeeping for the product will be subject to extensive and ongoing
10-K
2023 FY
NAMS
NewAmsterdam Pharma Company NV
28 Feb 24
Annual report
8:00am
also increases the removal of ApoB. Apolipoproteins are proteins that are involved in packaging different types of large lipid-particle complexes … , manufacture, quality control, approval, labeling, packaging, storage, record-keeping, promotion, advertising, distribution, post-approval monitoring
424B3
NAMS
NewAmsterdam Pharma Company NV
15 Aug 23
Prospectus supplement
4:52pm
, development, testing, manufacturing, labeling, packaging, approval, promotion, advertising, storage, recordkeeping, marketing, distribution, post-approval … , the EMA or other comparable regulatory authority approves obicetrapib, the manufacturing processes, labeling, packaging, distribution, adverse event
POS AM
NAMS
NewAmsterdam Pharma Company NV
7 Aug 23
Prospectus update (post-effective amendment)
7:56am
, labeling, packaging, approval, promotion, advertising, storage, recordkeeping, marketing, distribution, post-approval monitoring and reporting, and export … regulatory authority approves obicetrapib, the manufacturing processes, labeling, packaging, distribution, adverse event reporting, storage, advertising
6-K
EX-99.2
NAMS
NewAmsterdam Pharma Company NV
7 Aug 23
Research and development expenses
7:24am
regulatory approval for obicetrapib, our business will be substantially harmed.
The research, development, testing, manufacturing, labeling, packaging … comparable regulatory authority approves obicetrapib, the manufacturing processes, labeling, packaging, distribution, adverse event reporting, storage
424B3
cvriwca8xhnu71u
8 Jun 23
Prospectus supplement
5:01pm
424B3
mls7ovlw97rt1
6 Jun 23
Prospectus supplement
4:20pm
424B3
21wzg12v3iyuo4r0jiw
25 Apr 23
Prospectus supplement
8:14am
POS AM
kjuu sjfa643m2
17 Apr 23
Prospectus update (post-effective amendment)
9:09am
F-1
3x45h16
19 Dec 22
Registration statement (foreign)
6:22pm
6-K
EX-2.1
g099krx
23 Nov 22
Current report (foreign)
4:36pm
424B3
b41y4tp86sl 0j8xp1
18 Oct 22
Prospectus supplement
4:41pm
F-4/A
tl6od8ql8isgk9dfwd3
13 Oct 22
Registration of securities (foreign) (amended)
5:18pm
F-4/A
fv15q 7s4nrh7o
3 Oct 22
Registration of securities (foreign) (amended)
5:12pm
F-4/A
1vg7i8p990ju aulbos
13 Sep 22
Registration of securities (foreign) (amended)
5:03pm
F-4
s8g09y0v
4 Aug 22
Registration of securities (foreign)
8:02am
F-4
EX-10.8
8e14xml6i1g07byg
4 Aug 22
Registration of securities (foreign)
8:02am
- Prev
- 1
- Next